491 results on '"Braziel, Rita M."'
Search Results
2. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets
3. Supplementary Fig. 3 from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms
4. Supplementary Fig. 2 from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms
5. Supplementary Table 2 from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms
6. Supplementary Fig. 5 from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms
7. Supplementary Fig. 4 from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms
8. Supplementary Table 1 from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms
9. Data from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms
10. Supplementary Fig. 1 from Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms
11. B-Cell Malignancies
12. Data from A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
13. CCR Translation for the Article from A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
14. Supplementary Figure 1 from A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab
15. CCR Translation for This Article from BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab
16. Supplementary Table 1 from A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab
17. Supplementary Table 2 from A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab
18. Supplementary Figure Legends 1-3, Tables 1-3 from BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab
19. Supplementary Figures 1-3 from BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab
20. Supplementary Data from A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
21. Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma
22. BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma
23. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
24. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma
25. B-Cell Lymphomas
26. Multiplex high-throughput gene mutation analysis in acute myeloid leukemia
27. A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma
28. Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis
29. Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma
30. Mutation and Genomic Deletion Status of ataxia telangiectasia mutated (ATM) and p53 Confer Specific Gene Expression Profiles in Mantle Cell Lymphoma
31. Gene rearrangements in malignant lymphomas
32. Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling
33. Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations
34. IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas
35. MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma
36. Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP
37. Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study
38. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma
39. Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features
40. Expression of vascular endothelial growth factor and its receptors in rosacea
41. Molecular diagnosis of Burkitt's lymphoma
42. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
43. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
44. Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions
45. B-Cell Lymphomas
46. Detection of bcl-2/J(sub H) translocation by polymerase chain reaction: a summary of the experience of the molecular oncology survey of the College of American Pathologists
47. Oncogenically active MYD88 mutations in human lymphoma
48. Mast cell sarcoma with concurrent mast cell leukaemia
49. Intraclonal Heterogeneity Caused By Activation-Induced Cytidine Deaminase Is Not a Prognostic Biomarker in Untreated Advanced Stage Follicular Lymphoma: An Analysis of SWOG S0016
50. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.